{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:50:42Z","timestamp":1770994242285,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ymgme.2010.09.010","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T09:46:57Z","timestamp":1286185617000},"page":"111-115","source":"Crossref","is-referenced-by-count":62,"title":["Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI"],"prefix":"10.1016","volume":"102","author":[{"given":"Sean","family":"Turbeville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Nicely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Douglas","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya L.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell E.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmem","family":"Bonfim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal","family":"Al-Seraihy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.09.010_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00288275","article-title":"Chromosomal localization of ARSB, the gene for human N-acetylgalactosamine-4-sulphatase","volume":"82","author":"Litjens","year":"1989","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0010","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1542\/peds.2008-0635","article-title":"Lysosomal storage disorders in the newborn","volume":"123","author":"Staretz-Chacham","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1651-2227.2008.00965.x","article-title":"Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence","volume":"97","author":"Malm","year":"2008","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","article-title":"Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"134","author":"Swiedler","year":"2005","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0040","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00431-003-1348-y","article-title":"Lysosomal storage disorders: emerging therapeutic options require early diagnosis","volume":"162","author":"Meikle","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archneur.60.3.322","article-title":"Insights into the diagnosis and treatment of lysosomal storage diseases","volume":"60","author":"Wenger","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0050","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0055","series-title":"Naglazyme\u00ae (galsulfase) Solution for Intravenous Infusion Prescribing Information","author":"BioMarin Pharmaceutical","year":"2005"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0065","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3748\/wjg.14.4977","article-title":"Update and actual trends on bacterial infections following liver transplantation","volume":"14","author":"del Pozo","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0070","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2007.01.011","article-title":"The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I","volume":"91","author":"Pastores","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with Hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0085","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0095","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12519-008-0031-9","article-title":"Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation","volume":"4","author":"Wang","year":"2008","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0110","first-page":"825","article-title":"Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0115","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0120","series-title":"Survival Analysis: Techniques of Censored and Truncated Data","author":"Klein","year":"2003"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00431-008-0910-z","article-title":"Mucopolysaccharidosis VI: the Italian experience","volume":"168","author":"Scarpa","year":"2009","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.pediatrneurol.2003.09.003","article-title":"The status of hematopoietic stem cell transplantation in lysosomal storage disease","volume":"29","author":"Malatack","year":"2003","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","article-title":"New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy","volume":"121","author":"Beck","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","article-title":"Hematopoietic cell therapy for metabolic disease","volume":"151","author":"Orchard","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0155","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1038\/bmt.2008.62","article-title":"The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update","volume":"41","author":"Rovelli","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymgme.2010.09.010_bb0165","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2010.09.010_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","volume":"7","author":"Grewal","year":"2005","journal-title":"Genet. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210003549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T10:10:26Z","timestamp":1591956626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210003549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1096719210003549"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}